miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma

Glioblastoma multiforme (GBM) is a lethal, therapy-resistant brain cancer consisting of numerous tumor cell subpopulations, including stem-like glioma-initiating cells (GICs), which contribute to tumor recurrence following initial response to therapy. Here, we identified miR-182 as a regulator of ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Kouri, Fotini M., Hurley, Lisa A., Daniel, Weston L., Day, Emily S., Hua, Youjia, Hao, Liangliang, Peng, Chian-Yu, Merkel, Timothy J., Queisser, Markus A., Ritner, Carissa, Zhang, Hailei, James, C. David, Sznajder, Jacob I., Chin, Lynda, Giljohann, David A., Kessler, John A., Peter, Marcus E., Mirkin, Chad A., Stegh, Alexander H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory Press 2015
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387715/
https://www.ncbi.nlm.nih.gov/pubmed/25838542
http://dx.doi.org/10.1101/gad.257394.114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387715/
https://www.ncbi.nlm.nih.gov/pubmed/25838542
http://dx.doi.org/10.1101/gad.257394.114

Ejemplares similares